Renal drug metabolism in humans: the potential for drug-endobiotic interactions involving cytochrome P450 (CYP) and UDP-glucuronosyltransferase (UGT).
about
Role of endoplasmic reticulum stress in drug-induced toxicityCytochrome P450 eicosanoids in hypertension and renal diseaseMining kidney toxicogenomic data by using gene co-expression modulesQuantitative profiling of human renal UDP-glucuronosyltransferases and glucuronidation activity: a comparison of normal and tumoral kidney tissuesEffect of Kidney Function on Drug Kinetics and Dosing in Neonates, Infants, and ChildrenBioactivation of Heterocyclic Aromatic Amines by UDP Glucuronosyltransferases.Scaling factors for the in vitro-in vivo extrapolation (IV-IVE) of renal drug and xenobiotic glucuronidation clearanceMolecular mechanisms and cell signaling of 20-hydroxyeicosatetraenoic acid in vascular pathophysiology.Inter-isoform Hetero-dimerization of Human UDP-Glucuronosyltransferases (UGTs) 1A1, 1A9, and 2B7 and Impacts on Glucuronidation Activity.Drug Metabolism in Preclinical Drug Development: A Survey of the Discovery Process, Toxicology, and Computational Tools.In Vitro Glucuronidation of Wushanicaritin by Liver Microsomes, Intestine Microsomes and Expressed Human UDP-Glucuronosyltransferase Enzymes.Temporal Changes in Skeletal Muscle Capillary Responses and Endothelial-Derived Vasodilators in Obesity-Related Insulin Resistance.Human UDP-Glucuronosyltransferase 2B4 and 2B7 Are Responsible for Naftopidil Glucuronidation in Vitro.Glycine N-methyltransferase inhibits aristolochic acid nephropathy by increasing CYP3A44 and decreasing NQO1 expression in female mouse hepatocytes.Urinary Elimination of Bile Acid Glucuronides under Severe Cholestatic Situations: Contribution of Hepatic and Renal Glucuronidation Reactions.
P2860
Q26765518-386A1933-A4AB-4FC6-8B58-5A2F552ADDEDQ28252210-3BBD12D5-75CC-4A47-8F4D-75B30BBF5DDDQ28822270-072F99C8-E571-4FED-8C3D-CE77380D7734Q35197861-6E6584B3-6D56-4AFF-96D9-9A43670842FFQ36322918-F2610297-1761-4B3E-AC2E-E5B7BC0BF5EDQ36905502-E35ECA6F-7FD2-4CDF-8ECF-083921A5FD42Q36924729-762F420F-7129-4749-93B8-B2C0059CEFA4Q37340856-CCDD260D-247C-44A1-829E-BC98475C2D41Q37422055-D0869AC6-97C4-4ED8-92E0-723E756D03B9Q39182452-005221D9-7CF2-48F2-A7AE-7DF72098E970Q41660342-101EA72D-1D8D-43EB-A8EB-E961A6163C77Q42198780-93C1057C-CAB7-41EA-8E4F-84152D6A1310Q49631969-252257D0-EA3A-48BC-B963-83F055057A0AQ54221497-9F5A22DF-6176-4297-BDB8-583B3A4B1E7EQ55037290-070182BD-4FB0-4B4F-80A4-C523A7E60209
P2860
Renal drug metabolism in humans: the potential for drug-endobiotic interactions involving cytochrome P450 (CYP) and UDP-glucuronosyltransferase (UGT).
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Renal drug metabolism in human ...... glucuronosyltransferase (UGT).
@ast
Renal drug metabolism in human ...... glucuronosyltransferase (UGT).
@en
Renal drug metabolism in human ...... ions involving cytochrome P450
@nl
type
label
Renal drug metabolism in human ...... glucuronosyltransferase (UGT).
@ast
Renal drug metabolism in human ...... glucuronosyltransferase (UGT).
@en
Renal drug metabolism in human ...... ions involving cytochrome P450
@nl
prefLabel
Renal drug metabolism in human ...... glucuronosyltransferase (UGT).
@ast
Renal drug metabolism in human ...... glucuronosyltransferase (UGT).
@en
Renal drug metabolism in human ...... ions involving cytochrome P450
@nl
P2860
P356
P1476
Renal drug metabolism in human ...... -glucuronosyltransferase (UGT)
@en
P2093
John O Miners
Kathleen M Knights
P2860
P304
P356
10.1111/BCP.12086
P407
P577
2013-10-01T00:00:00Z